BioScience Health Innovations BHIC
OTC BHIC
$4.01 -0.99 (-19.80%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioScience Health Innovations (BHIC) Cash from Investing Activities (2024 - 2026)

BioScience Health Innovations (BHIC) posted quarterly Cash from Investing Activities of -$10786.0 for Q4 2025, up 43.23% year-over-year from -$7530.5 in Q4 2024, and up 32.86% quarter-over-quarter from -$16064.0 in Q2 2025.

BioScience Health Innovations (BHIC) Cash from Investing Activities (2024 - 2026) Analysis & Trends

BioScience Health Innovations (BHIC) has reported Cash from Investing Activities for 2 consecutive years, with -$10786.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash from Investing Activities rose 43.23% year-over-year to -$10786.0; the TTM figure through Mar 2026 stood at -$26850.0 (up 52.09% YoY), while the FY2025 annual figure was -$56850.0, down 118.34% from the prior year.
  • Cash from Investing Activities grew to -$10786.0 in Q4 2025 per BHIC's latest filing, from -$16064.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$7037.0 in Q3 2024 and bottomed at -$30000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 High Tide 215.72 Mn 182.44 Mn 35.30 Mn -1.65 Mn
2 BioScience Health Innovations 58.76 Mn 58.05 Mn 659,483.00 -26,958.00
3 Petmed Express 38.29 Mn 25.19 Mn 11.33 Mn -641,000.00
4 Scienture Holdings 17.81 Mn 17.81 Mn 335,779.00 -
5 Polomar Health Services 8.48 Mn 8.31 Mn 935,916.00 -
6 Ridgetech 58,214.34 -17.85 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 -26,958.00
Jun 30, 2026 -26,958.00
Dec 31, 2025 -10,786.00
Dec 31, 2025 -10,786.00
Jun 30, 2025 -16,064.00
Jun 30, 2025 -16,064.00
Mar 31, 2025 -30,000.00
Mar 31, 2025 -30,000.00
Dec 31, 2024 -19,000.00
Dec 31, 2024 -19,000.00
Sep 30, 2024 -7,037.00
Sep 30, 2024 -7,037.00